Studies on experimental models of ischemic stroke and subarachnoid hemorrhage indicate that GLP-1R agonists and analogs can promote the phosphorylation of PI3K and AKT, inhibit inflammatory responses, and thereby provide neuroprotective and vasculoprotective effects [16, 17]. The gene discussed is GLP1R; the disease is subarachnoid hemorrhage.